by City of Hope National Medical Center Mammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public Domain City of Hope, a world-renowned cancer research and treatment center, has identified how cancer cells in patients with early-stage breast cancer change and become resistant to hormone or combination therapies, according to a new study published...
CLEMSON UNIVERSITY IMAGE: CLEMSON UNIVERSITY BIOLOGICAL SCIENCES PROFESSOR YANZHANG (CHARLIE) WEI HAS DEVELOPED A BIFUNCTIONAL PROTEIN THAT BRIDGES THE HUMAN BODY’S NATURAL KILLER CELLS AND BREAST CANCER TUMOR CELLS. CREDIT: CLEMSON UNIVERSITY It sounds like a plot from a Quentin Tarantino movie — something sets off natural killers and sends them on a killing spree....
by McGill University Credit: McGill University Breast cancer is the leading cause of cancer death in women around the world, responsible for 1,700 deaths every day. Although the vast majority of breast cancers are treatable, the most aggressive subtype—triple negative breast cancer (TNBC) – has a high recurrence rate, a high potential for metastasis, and shows...
by Jeffrey Norris, University of California, San Francisco Credit: NIH What kills most people who die from cancer is not the initial tumor. It’s the intolerable disease burden on the body that arises when tumor cells continually expand their numbers after spreading to different organs. In comparison to what is already known about specific mutations that...
EXPERIMENTAL BIOLOGY IMAGE: THE RESEARCHERS USED THE PLANT COMPOUND SANGUINARINE TO TREAT TWO GROUPS OF TRIPLE NEGATIVE BREAST CANCER CELLS — ONE DERIVED FROM WOMEN WITH AFRICAN AMERICAN ANCESTRY AND THE OTHER FROM WOMEN OF EUROPEAN ORIGIN. CREDIT: SAMIA MESSEHA, FLORIDA AGRICULTURAL AND MECHANICAL UNIVERSITY Findings from a new cell study suggest that the natural...
by Virginia Commonwealth University Charles Clevenger, M.D., Ph.D. Credit: VCU Massey Cancer Center The hormone prolactin has long been understood to play a vital role in breast growth and development and the production of milk during pregnancy. But a pair of recent studies conducted at VCU Massey Cancer Center finds strong evidence that prolactin also acts...
THE UNIVERSITY OF BERGEN Targeted therapy in early stages of breast cancer can pave the way for a notable higher success rate, shows a study from the University of Bergen, Norway (UiB). PARP (Poly (ADP-ribose) polymerase) inhibitors represent an established targeted therapy for multiple cancer types, including cancers of the prostate, ovary and rare cases...
by Garvan Institute of Medical Research Microscopy image of mammary gland alveoli during lactation. Credit: Dr David Gallego-Ortega New research led by the Garvan Institute of Medical Research has revealed how breast cancer cells that develop during or after pregnancy change their environment to form more aggressive tumors. In experimental models of pregnancy associated breast cancer, researchers found that cancer cells...
by Max Delbrück Center for Molecular Medicine Immunofluorescence image of the post-partum mouse mammary gland showing membrane bound B-catenin (white) and nuclei (blue). Credit: Birchmeier Lab, MDC Breast cancer is the most common type of tumor found in women. Each year in Germany alone, 69,000 new cases are diagnosed. Around 80 percent of tumors originate in...
by National University of Singapore Credit: Pixabay/CC0 Public Domain Breast cancer is the most common cancer in women worldwide and the second most common cancer overall. Although it can now be treated with drugs, many of these drugs mysteriously stop working after some time, causing a relapse. Now a team of researchers from the Cancer Science...
